Cargando…

Rosmarinic acid reverses non‐small cell lung cancer cisplatin resistance by activating the MAPK signaling pathway

Cisplatin (DDP) is one of the first‐line chemotherapeutic agents for non‐small cell lung cancer (NSCLC). However, repeated use of cisplatin in clinical practice often induces chemoresistance. The aims of this study were to investigate whether rosmarinic acid (RA) could reverse multidrug resistance (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Xiao‐Zhong, Gao, Ying, Sun, Ling‐Ling, Liu, Jia‐Hui, Chen, Han‐Rui, Yu, Ling, Chen, Zhuang‐Zhong, Chen, Wen‐Hui, Lin, Li‐Zhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd. 2020
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217221/ https://www.ncbi.nlm.nih.gov/pubmed/31985119 http://dx.doi.org/10.1002/ptr.6584

Ejemplares similares

Tanshinone IIA combined with cisplatin synergistically inhibits non‐small‐cell lung cancer in vitro and in vivo via down‐regulating the phosphatidylinositol 3‐kinase/Akt signalling pathway
por: Liao, Xiao‐Zhong, et al.
Publicado: (2019)

Cordycepin Reverses Cisplatin Resistance in Non-small Cell Lung Cancer by Activating AMPK and Inhibiting AKT Signaling Pathway
por: Liao, Xiao-Zhong, et al.
Publicado: (2021)

Rosmarinic acid down‐regulates NO and PGE (2) expression via MAPK pathway in rat chondrocytes
por: Chen, We‐Ping, et al.
Publicado: (2017)

Parthenolide Augments the Chemosensitivity of Non-small-Cell Lung Cancer to Cisplatin via the PI3K/AKT Signaling Pathway
por: Wu, Li-Mei, et al.
Publicado: (2021)

ERK/MAPK signalling pathway and tumorigenesis
por: Guo, Yan-Jun, et al.
Publicado: (2020)

Metabolic modeling of Rosmarinic acid biosynthetic pathway
por: Sundaram, Shanthy, et al.
Publicado: (2010)

Rosmarinic Acid Attenuates the Lipopolysaccharide-Provoked Inflammatory Response of Vascular Smooth Muscle Cell via Inhibition of MAPK/NF-κB Cascade
por: Chen, Ching-Pei, et al.
Publicado: (2022)

Lipid Mediators Metabolic Chaos of Asthmatic Mice Reversed by Rosmarinic Acid
por: Qin, Tuo, et al.
Publicado: (2023)

Rosmarinic Acid Methyl Ester Regulates Ovarian Cancer Cell Migration and Reverses Cisplatin Resistance by Inhibiting the Expression of Forkhead Box M1
por: Lim, Soo Hyun, et al.
Publicado: (2020)

Rosmarinic acid potentiates carnosic acid induced apoptosis in lung fibroblasts
por: Bahri, Sana, et al.
Publicado: (2017)

Molecular cloning and characterization of rosmarinic acid biosynthetic genes and rosmarinic acid accumulation in Ocimum basilicum L.
por: Kwon, Do Yeon, et al.
Publicado: (2019)

Protective effect of taurine on sepsis-induced lung injury via inhibiting the p38/MAPK signaling pathway
por: Chen, Jiao, et al.
Publicado: (2021)

Rosmarinic Acid Ameliorates Pulmonary Ischemia/Reperfusion Injury by Activating the PI3K/Akt Signaling Pathway
por: Luo, Wenbin, et al.
Publicado: (2022)

Delicaflavone Reverses Cisplatin Resistance via Endoplasmic Reticulum Stress Signaling Pathway in Non-Small Cell Lung Cancer Cells
por: Wang, Xuewen, et al.
Publicado: (2020)

Deciphering the therapeutical potentials of rosmarinic acid
por: El Kantar, Sally, et al.
Publicado: (2022)

Metabolic Engineering of Saccharomyces cerevisiae for Rosmarinic Acid Production
por: Babaei, Mahsa, et al.
Publicado: (2020)

Rosmarinic acid suppresses tau phosphorylation and cognitive decline by downregulating the JNK signaling pathway
por: Yamamoto, So, et al.
Publicado: (2021)

Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells
por: Du, Juan, et al.
Publicado: (2017)

Rosmarinic acid ameliorates hypoxia/ischemia induced cognitive deficits and promotes remyelination
por: Li, Man, et al.
Publicado: (2019)

The Apoptotic Effect of Ursolic Acid on SK-Hep-1 Cells is Regulated by the PI3K/Akt, p38 and JNK MAPK Signaling Pathways
por: Chuang, Wan-Ling, et al.
Publicado: (2016)

Anti-enterovirus 71 activities of Melissa officinalis extract and its biologically active constituent rosmarinic acid
por: Chen, Sin-Guang, et al.
Publicado: (2017)

Rosmarinic Acid Prevents Cisplatin-Induced Liver and Kidney Injury by Inhibiting Inflammatory Responses and Enhancing Total Antioxidant Capacity, Thereby Activating the Nrf2 Signaling Pathway
por: Xiang, Yifei, et al.
Publicado: (2022)

Biomedical features and therapeutic potential of rosmarinic acid
por: Noor, Saba, et al.
Publicado: (2022)

Magnetite Microspheres for the Controlled Release of Rosmarinic Acid
por: Chircov, Cristina, et al.
Publicado: (2022)

Retrospective study of irinotecan/cisplatin followed by etoposide/cisplatin or the reverse sequence in extensive-stage small cell lung cancer
por: Xiao, Xiaoguang, et al.
Publicado: (2015)

Hesperetin reverses P-glycoprotein-mediated cisplatin resistance in DDP-resistant human lung cancer cells via modulation of the nuclear factor-κB signaling pathway
por: Kong, Wencui, et al.
Publicado: (2020)

Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway
por: Zhu, Hui-er, et al.
Publicado: (2019)

Rosmarinic Acid Inhibits Mitochondrial Damage by Alleviating Unfolded Protein Response
por: Cai, Guoen, et al.
Publicado: (2022)

PD‐0332991 combined with cisplatin inhibits nonsmall cell lung cancer and reversal of cisplatin resistance
por: Liu, Minghui, et al.
Publicado: (2021)

Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway
por: Chen, Yun, et al.
Publicado: (2020)

HNF4G increases cisplatin resistance in lung adenocarcinoma via the MAPK6/Akt pathway
por: Liang, Jiaqi, et al.
Publicado: (2023)

Rosmarinic acid monotherapy is better than the combination of rosmarinic acid and telmisartan in preventing podocyte detachment and inhibiting the progression of diabetic nephropathy in rats
por: Samsu, Nur, et al.
Publicado: (2019)

Rosmarinic Acid Induces Proliferation Suppression of Hepatoma Cells Associated with NF-κB Signaling Pathway
por: An, Yanjun, et al.
Publicado: (2021)

Identification of a novel S6K1 inhibitor, rosmarinic acid methyl ester, for treating cisplatin-resistant cervical cancer
por: Nam, Ki Hong, et al.
Publicado: (2019)

Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway
por: Yuan, Yu-hong, et al.
Publicado: (2019)

Exogenous Rosmarinic Acid Application Enhances Thermotolerance in Tomatoes
por: Zhou, Zhiwen, et al.
Publicado: (2022)

Rosmarinic acid ameliorates HCl-induced cystitis in rats
por: Kitamura, Naoya, et al.
Publicado: (2023)

TTI1 promotes non‐small‐cell lung cancer progression by regulating the mTOR signaling pathway
por: Zhang, Ling‐Xian, et al.
Publicado: (2022)

Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling
por: Wang, L-H, et al.
Publicado: (2014)

Pharmacokinetic and Pharmacodynamic Properties of Rosmarinic Acid in Rat Cholestatic Liver Injury
por: Min, Jianbin, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_p6c6iopl1chfclojgkscpoja6a